Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Probability Laws01:49

Probability Laws

Overview
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pedigree Analysis01:35

Pedigree Analysis

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stage-stratified prognostic impact of comorbidities on breast cancer-specific survival: A population-based flexible parametric modelling study.

Cancer epidemiology·2026
Same author

A data-informed multidimensional composite score for stress assessment.

Acta psychologica·2026
Same author

Bayesian uncertainty quantification to identify population level vaccine hesitancy behaviours.

PloS one·2026
Same author

A localised risk model for liver fluke infection.

Veterinary parasitology, regional studies and reports·2026
Same author

Development and implementation of a data parsing protocol for companion animal cancer data.

Veterinary pathology·2026
Same author

Inter-Observer variability in organs at risk contouring among radiation therapy students and qualified radiation therapists.

Technical innovations & patient support in radiation oncology·2025

Related Experiment Video

Updated: Jul 6, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Calculation of IBD probabilities with dense SNP or sequence data.

Jonathan M Keith1, Allan McRae, David Duffy

  • 1School of Mathematical Sciences, Queensland University of Technology, Brisbane, Qld. 4001, Australia. j.keith.@qut.edu.au

Genetic Epidemiology
|March 22, 2008
PubMed
Summary

A new Markov chain model accurately estimates identity by descent (IBD) probabilities faster than existing methods. This approach accounts for genotyping errors and linkage disequilibrium, crucial for genetic mapping and association studies.

More Related Videos

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Related Experiment Videos

Last Updated: Jul 6, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Area of Science:

  • Genetics
  • Bioinformatics
  • Computational Biology

Background:

  • Estimating identity by descent (IBD) probabilities is crucial for genetic studies like disease gene mapping.
  • Traditional methods assumed sparse markers and linkage equilibrium, which are no longer valid with high-throughput genotyping.

Purpose of the Study:

  • To develop a novel, efficient algorithm for calculating IBD probabilities.
  • To incorporate genotyping errors and linkage disequilibrium into IBD estimation.

Main Methods:

  • A new model representing founder haplotypes as a Markov chain.
  • Explicit inclusion of genotyping errors in the model.
  • Comparison with the Merlin software package, with and without its linkage disequilibrium cluster model.

Main Results:

  • The new model achieves accuracy comparable to Merlin with haplotype blocks.
  • The Markov chain model demonstrates significantly faster run times (orders of magnitude).
  • The algorithm exhibits linear scaling with the number of markers, unlike Merlin's supralinear scaling.

Conclusions:

  • The proposed Markov chain model offers a computationally efficient and accurate method for IBD probability estimation.
  • Accounting for linkage disequilibrium is essential for accurate IBD calculations.
  • The model is well-suited for current and future high-density genotyping and sequencing data.